Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors

NCT00827177

Conditions: Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +38 more
Locations: Boston, Massachusetts, United States

Roswell Park Cancer Institute Buffalo, New York, United States

Nashville, Tennessee, United States

Rozzano, Italy

View Trial Details

Completed

Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells

NCT00672542

Conditions: Absence of CNS Metastases, Melanoma, Metastatic Melanoma, +11 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis

NCT00004196

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

James Graham Brown Cancer Center at University of Louisville Louisville, Kentucky, United States

Cancer Institute of New Jersey New Brunswick, New Jersey, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Rapamycin With Grapefruit Juice for Advanced Malignancies

NCT00375245

Conditions: Adenoma, Adnexal Diseases, Breast Diseases, +73 more
Locations: University of Chicago Hospitals Chicago, Illinois, United States

View Trial Details

Completed

Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma

NCT00436930

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Hoag Cancer Institute at Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

View Trial Details

Completed

Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study

NCT00462423

Conditions: Melanoma, Metastatic Malignant Melanoma, Neoplasms, +10 more
Locations: Northern California Melanoma Center San Francisco, California, United States

The Angeles Clinic and Research Institute Santa Monica, California, United States

View Trial Details

Completed

Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma

NCT00016263

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Genta Incorporated Berkeley Heights, New Jersey, United States

View Trial Details

Completed

SciBase International Melanoma Pivotal Study

NCT01077050

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: University of Arizona Tucson, Arizona, United States

Sahlgrenska University Hospital Gothenburg, Sweden

View Trial Details

Completed

Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma

NCT00002892

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Royal Free Hospital Hampstead, London, England, United Kingdom

St. James's Hospital Leeds, England, United Kingdom

University Hospitals of Leicester Leicester, England, United Kingdom

Guy's, King's and St. Thomas' Hospitals Trust London, England, United Kingdom

View all 14 locations

View Trial Details

Completed

ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma

NCT00081042

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions